Thermo Fisher Scientific's Revenue
- Thermo Fisher Scientific's annual revenue was $42.86B in fiscal year 2023. The annual revenue decreased -$2.06B from $44.92B (in 2022) to $42.86B (in 2023), representing a -4.58% year-over-year decline.
- Thermo Fisher Scientific's quarterly revenue was $10.60B in the quarter ending Sep 2024. The quarterly revenue increased $24.00M from $10.57B (in Q3: June 2023) to $10.60B (in Q3: June 2024), representing a 0.23% year-over-year growth.
- The highest annual revenue for Thermo Fisher Scientific was $44.92B in fiscal year 2022.
- The lowest annual revenue was $16.97B in fiscal year 2015.
- The average revenue was $29.47B.
- Revenue is the amount of money generated by a business from sales of its goods or services. Refer to our glossary for more details, examples, and formulas.
Over the past 10 years (2015 - 2024):
Learn more about Thermo Fisher Scientific's Revenue by Segment and Revenue by Region.
Check out competitors to Thermo Fisher Scientific in a side-by-side comparison.
Explore additional financial metrics for Thermo Fisher Scientific.
Definition of Revenue :
| 2014 | 16889600000.00 |
|---|---|
| 2015 | 16965400000.00 |
| 2016 | 18274100000.00 |
| 2017 | 20918000000.00 |
| 2018 | 24358000000.00 |
| 2019 | 25542000000.00 |
| 2020 | 32218000000.00 |
| 2021 | 39211000000.00 |
| 2022 | 44915000000.00 |
| 2023 | 42857000000.00 |
| Mar 2015 | 3918800000.00 |
|---|---|
| Jun 2015 | 4270900000.00 |
| Sep 2015 | 4123200000.00 |
| Dec 2015 | 4652500000.00 |
| Apr 2016 | 4294800000.00 |
| Jul 2016 | 4535200000.00 |
| Oct 2016 | 4490900000.00 |
| Dec 2016 | 4953200000.00 |
| Apr 2017 | 4765000000.00 |
| Jul 2017 | 4990000000.00 |
| Sep 2017 | 5116200000.00 |
| Dec 2017 | 6047000000.00 |
| Mar 2018 | 5853000000.00 |
| Jun 2018 | 6078000000.00 |
| Sep 2018 | 5920000000.00 |
| Dec 2018 | 6507000000.00 |
| Mar 2019 | 6125000000.00 |
| Jun 2019 | 6316000000.00 |
| Sep 2019 | 6272000000.00 |
| Dec 2019 | 6829000000.00 |
| Mar 2020 | 6230000000.00 |
| Jun 2020 | 6917000000.00 |
| Sep 2020 | 8521000000.00 |
| Dec 2020 | 10550000000.00 |
| Apr 2021 | 9906000000.00 |
| Jul 2021 | 9273000000.00 |
| Oct 2021 | 9330000000.00 |
| Dec 2021 | 10702000000.00 |
| Apr 2022 | 11818000000.00 |
| Jul 2022 | 10970000000.00 |
| Oct 2022 | 10677000000.00 |
| Dec 2022 | 11450000000.00 |
| Apr 2023 | 10710000000.00 |
| Jul 2023 | 10687000000.00 |
| Sep 2023 | 10574000000.00 |
| Dec 2023 | 10886000000.00 |
| Mar 2024 | 10345000000.00 |
| Jun 2024 | 10541000000.00 |
| Sep 2024 | 10598000000.00 |
2023
Thermo Fisher Scientific's annual revenue was $42.86B in fiscal year 2023.
Thermo Fisher Scientific's quarterly revenue was $10.71B(Q1: Apr 2023), $10.69B(Q2: Jul 2023), $10.57B(Q3: Sep 2023), $10.89B(Q4: Dec 2023) in fiscal year 2023.
2022
Thermo Fisher Scientific's annual revenue was $44.92B in fiscal year 2023.
Thermo Fisher Scientific's quarterly revenue was $11.82B(Q1: Apr 2022), $10.97B(Q2: Jul 2022), $10.68B(Q3: Oct 2022), $11.45B(Q4: Dec 2022) in fiscal year 2022.
2021
Thermo Fisher Scientific's annual revenue was $39.21B in fiscal year 2023.
Thermo Fisher Scientific's quarterly revenue was $9.91B(Q1: Apr 2021), $9.27B(Q2: Jul 2021), $9.33B(Q3: Oct 2021), $10.70B(Q4: Dec 2021) in fiscal year 2021.
2020
Thermo Fisher Scientific's annual revenue was $32.22B in fiscal year 2023.
Thermo Fisher Scientific's quarterly revenue was $6.23B(Q1: Mar 2020), $6.92B(Q2: Jun 2020), $8.52B(Q3: Sep 2020), $10.55B(Q4: Dec 2020) in fiscal year 2020.
2019
Thermo Fisher Scientific's annual revenue was $25.54B in fiscal year 2023.
Thermo Fisher Scientific's quarterly revenue was $6.13B(Q1: Mar 2019), $6.32B(Q2: Jun 2019), $6.27B(Q3: Sep 2019), $6.83B(Q4: Dec 2019) in fiscal year 2019.
2018
Thermo Fisher Scientific's annual revenue was $24.36B in fiscal year 2023.
Thermo Fisher Scientific's quarterly revenue was $5.85B(Q1: Mar 2018), $6.08B(Q2: Jun 2018), $5.92B(Q3: Sep 2018), $6.51B(Q4: Dec 2018) in fiscal year 2018.
2017
Thermo Fisher Scientific's annual revenue was $20.92B in fiscal year 2023.
Thermo Fisher Scientific's quarterly revenue was $4.77B(Q1: Apr 2017), $4.99B(Q2: Jul 2017), $5.12B(Q3: Sep 2017), $6.05B(Q4: Dec 2017) in fiscal year 2017.
2016
Thermo Fisher Scientific's annual revenue was $18.27B in fiscal year 2023.
Thermo Fisher Scientific's quarterly revenue was $4.29B(Q1: Apr 2016), $4.54B(Q2: Jul 2016), $4.49B(Q3: Oct 2016), $4.95B(Q4: Dec 2016) in fiscal year 2016.
2015
Thermo Fisher Scientific's annual revenue was $16.97B in fiscal year 2023.
Thermo Fisher Scientific's quarterly revenue was $3.92B(Q1: Mar 2015), $4.27B(Q2: Jun 2015), $4.12B(Q3: Sep 2015), $4.65B(Q4: Dec 2015) in fiscal year 2015.
| 2014 | 0 |
|---|---|
| 2015 | +0.45 |
| 2016 | +7.71 |
| 2017 | +14.47 |
| 2018 | +16.45 |
| 2019 | +4.86 |
| 2020 | +26.14 |
| 2021 | +21.71 |
| 2022 | +14.55 |
| 2023 | -4.58 |
| Q1: Mar 15 | 0.39 |
|---|---|
| Q2: Jun 15 | -1.18 |
| Q3: Sep 15 | -1.16 |
| Q4: Dec 15 | 3.55 |
| Q1: Apr 16 | 9.59 |
| Q2: Jul 16 | 6.19 |
| Q3: Oct 16 | 8.92 |
| Q4: Dec 16 | 6.46 |
| Q1: Apr 17 | 10.95 |
| Q2: Jul 17 | 10.03 |
| Q3: Sep 17 | 13.92 |
| Q4: Dec 17 | 22.08 |
| Q1: Mar 18 | 22.83 |
| Q2: Jun 18 | 21.80 |
| Q3: Sep 18 | 15.71 |
| Q4: Dec 18 | 7.61 |
| Q1: Mar 19 | 4.65 |
| Q2: Jun 19 | 3.92 |
| Q3: Sep 19 | 5.95 |
| Q4: Dec 19 | 4.95 |
| Q1: Mar 20 | 1.71 |
| Q2: Jun 20 | 9.52 |
| Q3: Sep 20 | 35.86 |
| Q4: Dec 20 | 54.49 |
| Q1: Apr 21 | 59.00 |
| Q2: Jul 21 | 34.06 |
| Q3: Oct 21 | 9.49 |
| Q4: Dec 21 | 1.44 |
| Q1: Apr 22 | 19.30 |
| Q2: Jul 22 | 18.30 |
| Q3: Oct 22 | 14.44 |
| Q4: Dec 22 | 6.99 |
| Q1: Apr 23 | -9.38 |
| Q2: Jul 23 | -2.58 |
| Q3: Sep 23 | -0.96 |
| Q4: Dec 23 | -4.93 |
| Q1: Mar 24 | -3.41 |
| Q2: Jun 24 | -1.37 |
| Q3: Sep 24 | 0.23 |
2023
Thermo Fisher Scientific’s annual revenue decreased -4.58% during fiscal year 2023 compared to 2022. It represents a decline of -$2.06B from $44.92B (in 2022) to $42.86B (in 2023).
2022
Thermo Fisher Scientific’s annual revenue increased +14.55% during fiscal year 2022 compared to 2021. It represents a growth of $5.70B from $39.21B (in 2021) to $44.92B (in 2022).
2021
Thermo Fisher Scientific’s annual revenue increased +21.71% during fiscal year 2021 compared to 2020. It represents a growth of $6.99B from $32.22B (in 2020) to $39.21B (in 2021).
2020
Thermo Fisher Scientific’s annual revenue increased +26.14% during fiscal year 2020 compared to 2019. It represents a growth of $6.68B from $25.54B (in 2019) to $32.22B (in 2020).
2019
Thermo Fisher Scientific’s annual revenue increased +4.86% during fiscal year 2019 compared to 2018. It represents a growth of $1.18B from $24.36B (in 2018) to $25.54B (in 2019).
2018
Thermo Fisher Scientific’s annual revenue increased +16.45% during fiscal year 2018 compared to 2017. It represents a growth of $3.44B from $20.92B (in 2017) to $24.36B (in 2018).
2017
Thermo Fisher Scientific’s annual revenue increased +14.47% during fiscal year 2017 compared to 2016. It represents a growth of $2.64B from $18.27B (in 2016) to $20.92B (in 2017).
2016
Thermo Fisher Scientific’s annual revenue increased +7.71% during fiscal year 2016 compared to 2015. It represents a growth of $1.31B from $16.97B (in 2015) to $18.27B (in 2016).
2015
Thermo Fisher Scientific’s annual revenue increased +0.45% during fiscal year 2015 compared to 2014. It represents a growth of $75.80M from $16.89B (in 2014) to $16.97B (in 2015).
Summary Table (Annual)
| Period | Revenue | Year-over-Year Change |
|---|---|---|
| 2023 | $42.86B | -4.58% |
| 2022 | $44.92B | +14.55% |
| 2021 | $39.21B | +21.71% |
| 2020 | $32.22B | +26.14% |
| 2019 | $25.54B | +4.86% |
| 2018 | $24.36B | +16.45% |
| 2017 | $20.92B | +14.47% |
| 2016 | $18.27B | +7.71% |
| 2015 | $16.97B | +0.45% |
Summary Table (Quarterly)
| Period | Revenue | Year-over-Year Change |
|---|---|---|
| Q3: Sep 24 | $10.60B | 0.23% |
| Q2: Jun 24 | $10.54B | -1.37% |
| Q1: Mar 24 | $10.35B | -3.41% |
| Q4: Dec 23 | $10.89B | -4.93% |
| Q3: Sep 23 | $10.57B | -0.96% |
| Q2: Jul 23 | $10.69B | -2.58% |
| Q1: Apr 23 | $10.71B | -9.38% |
| Q4: Dec 22 | $11.45B | 6.99% |
| Q3: Oct 22 | $10.68B | 14.44% |
| Q2: Jul 22 | $10.97B | 18.30% |
| Q1: Apr 22 | $11.82B | 19.30% |
| Q4: Dec 21 | $10.70B | 1.44% |
| Q3: Oct 21 | $9.33B | 9.49% |
| Q2: Jul 21 | $9.27B | 34.06% |
| Q1: Apr 21 | $9.91B | 59.00% |
| Q4: Dec 20 | $10.55B | 54.49% |
| Q3: Sep 20 | $8.52B | 35.86% |
| Q2: Jun 20 | $6.92B | 9.52% |
| Q1: Mar 20 | $6.23B | 1.71% |
| Q4: Dec 19 | $6.83B | 4.95% |
| Q3: Sep 19 | $6.27B | 5.95% |
| Q2: Jun 19 | $6.32B | 3.92% |
| Q1: Mar 19 | $6.13B | 4.65% |
| Q4: Dec 18 | $6.51B | 7.61% |
| Q3: Sep 18 | $5.92B | 15.71% |
| Q2: Jun 18 | $6.08B | 21.80% |
| Q1: Mar 18 | $5.85B | 22.83% |
| Q4: Dec 17 | $6.05B | 22.08% |
| Q3: Sep 17 | $5.12B | 13.92% |
| Q2: Jul 17 | $4.99B | 10.03% |
| Q1: Apr 17 | $4.77B | 10.95% |
| Q4: Dec 16 | $4.95B | 6.46% |
| Q3: Oct 16 | $4.49B | 8.92% |
| Q2: Jul 16 | $4.54B | 6.19% |
| Q1: Apr 16 | $4.29B | 9.59% |
| Q4: Dec 15 | $4.65B | 3.55% |
| Q3: Sep 15 | $4.12B | -1.16% |
| Q2: Jun 15 | $4.27B | -1.18% |
| Q1: Mar 15 | $3.92B | 0.39% |
Related
-
Agilent Technologies Revenue
-
Eli Lilly and Company Revenue
-
Stryker Corporation Revenue
-
Johnson & Johnson Revenue
-
AbbVie Revenue
-
Merck & Co. Revenue
-
Abbott Laboratories Revenue
-
Danaher Corporation Revenue
-
Amgen Revenue
-
Pfizer Revenue
-
Boston Scientific Corporation Revenue
-
Bristol-Myers Squibb Company Revenue
-
Cigna Corporation Revenue
-
McKesson Corporation Revenue
-
Cardinal Health Revenue
-
Moderna Revenue
